Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x100px
Document › Details

Novozymes A/S. (8/8/19). "Press Release: Change to the Executive Leadership Team". Bagsværd.

Organisation Organisation Novozymes A/S
  Group Novozymes (Group)
Products Product industrial enzyme
  Product 2 industrial biotechnology
Persons Person Havranek-Kosicek, Prisca (Novo Group 201803c–201908 CFO of Novozymes A/S LEFT 8/19)
  Person 2 Nielsen, Peder Holk (Novo Group 201407 CEO of Novozymes)

Novozymes A/S and Prisca Havranek-Kosicek have mutually agreed that she will discontinue her position as EVP and CFO with immediate effect.

Jørgen Buhl Rasmussen, Chairman of the Board of Directors, and CEO Peder Holk Nielsen, comment: "Novozymes is the world leader in enzymes and microbes, and continues to develop the business, most recently with its strategy update 'Better business with biology,' which aims for higher growth and improved performance over the next three years. Novozymes A/S and Prisca Havranek-Kosicek have mutually agreed that she will discontinue her position as EVP and CFO with immediate effect for personal reasons. We would like to thank Prisca for her strong support over the past 18 months in driving the agenda on how to secure the delivery of our updated strategy. We wish Prisca every success in her future endeavors.”

Novozymes expects to announce a new appointment to the position soon.

The change has no impact on the financial outlook for 2019.

August 8, 2019
Company announcement No. 28

Contact information:

Tobias Bjorklund
+45 3077 8682

Carl Ahlgren
+45 3077 2783

Press and media:
René Tronborg (DK)
+45 3077 2274

About Novozymes

Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet’s resources and helping build better lives. As the world’s largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energyefficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow.

Novozymes A/S CVR number: 10 00 71 27 LEI: 529900T6WNZXD2R3JW38
Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd Denmark
Phone: +45 4446 0000

Record changed: 2023-06-05


Picture Berlin Partner Top News Tacalyx Extends Seed Round to €14m 650x200px

More documents for Novozymes (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group World of Partnering Opportunities 650x300px

» top